Compound: harmalol
SMILES: Oc1cc2[nH]c3C(=NCCc3c2cc1)C
InChIKey: RHVPEFQDYMMNSY-UHFFFAOYSA-N
Synonyms: harmalol, 525-57-5, Harmidol, Harmolol, 1-methyl-4,9-dihydro-3H-pyrido[3,4-b]indol-7-ol, 1-Methyl-4,9-dihydro-3H-beta-carbolin-7-ol, 2NQN80556Q, NSC-72293, 4,9-Dihydro-1-methyl-3H-pyrido(3,4-b)indol-7-ol, CHEBI:27943, DTXSID50894870, 4,9-Dihydro-1-methyl-3H-pyrido[3,4-b]indol-7-ol, 1-methyl-4,9-dihydro-3H-pyrido(3,4-b)indol-7-ol, RefChem:145266, DTXCID101324432, 208-375-4, MFCD00152093, 3H-Pyrido[3,4-b]indol-7-ol, 4,9-dihydro-1-methyl-, CHEMBL129177, 11-Hydroxyharmalan; NSC 72293, 1-methyl-3,4-dihydrobeta-carbolin-7-ol, 3H-Pyrido(3,4-b)indol-7-ol, 4,9-dihydro-1-methyl-, 1-Methyl-4,9-dihydro-3H-beta-carbolin-7-ol hydrochloride, MLS002153909, SMR001233258, EINECS 208-375-4, 1-methyl-3H,4H,9H-pyrido[3,4-b]indol-7-ol, UNII-2NQN80556Q, SR-01000636961, 4,9-Dihydro-1-methyl-3H-pyrido[3,4-b]indol-7-ol; 11-Hydroxyharmalan; NSC 72293;, NSC 72293, 3H-Pyrido[3,4-b]indol-7-ol,4,9-dihydro-1-methyl-, Spectrum_000421, HARMALINE_met004, HARMALOL [MI], Prestwick0_000611, Prestwick1_000611, Prestwick2_000611, Prestwick3_000611, Spectrum2_000556, Spectrum3_000721, Spectrum4_000767, Spectrum5_001307, bmse000988, bmse001010, BSPBio_000542, BSPBio_002242, KBioGR_001154, KBioSS_000901, BIDD:ER0514, DivK1c_000998, SCHEMBL555401, SPBio_000631, SPBio_002761, BPBio1_000598, orb1298646, SCHEMBL15821030, SCHEMBL30163266, BDBM60980, KBio1_000998, KBio2_000901, KBio2_003469, KBio2_006037, KBio3_001462, DTXSID90975692, cid_16667410, CRQDWQWZCNKKAC-UHFFFAOYSA-N, NINDS_000998, NSC72293, TNP00138, BDBM50132101, SBB005350, STL565316, AKOS005202957, EBC-462082, FH57648, SDCCGMLS-0066705.P001, IDI1_000998, SMP1_000145, 3H-Pyrido[3, 4,9-dihydro-1-methyl-, NCGC00017249-01, NCGC00017249-02, NCGC00142520-01, NCI60_013481, ST057238, TS-09883, 1-Methyl-4,9-dihydro-3H-?-carbolin-7-ol, 3,4-Dihydro-7-hydroxy-1-methyl-b-carboline, CS-0023033, NS00042837, C06537, A1-00785, SR-01000636961-5, 3,4-Dihydro-1-methyl-2H-Pyrido[3,4-b]indol-7-ol, BRD-K14756138-001-01-9, BRD-K14756138-003-02-3, BRD-K14756138-310-03-0, Q15138221, 2H-Pyrido[3,4-b]indol-7-ol, 3,4-dihydro-1-methyl-, 3,4-DIHYDRO-1-METHYL-9H-PYRIDO(3,4-B)INDOL-7-OL, 4,9-Dihydro-1-methyl-3H-pyrido[3,4-b]indol-7-ol, 9CI, 1-Methyl-2,3,4,9-tetrahydro-7H-pyrido[3,4-b]indol-7-one, 1-methyl-2,3,4,9-tetrahydro-beta-carbolin-7-one;hydrate;hydrochloride, 1-methyl-2,3,4,9-tetrahydropyrido[3,4-b]indol-7-one;hydrate;hydrochloride
Theoretical properties:
molecular_formula: C12H12N2O
molecular_weight: 200.24 g/mol
exact_mass: 200.094963011 g/mol
formal_charge: 0
hydrogen_bond_donor_count: 2
hydrogen_bond_acceptor_count: 2
rotatable_bond_count: 0
heavy_atom_count: 15
topological_polar_surface_area: 48.4 Å²
isotope_atom_count: 0
covalently_bonded_unit_count: 1
Physical properties:
melting_point: 100 - 105 °C
Descriptions:
pubchem: Harmalol is a harmala alkaloid in which the harman skeleton is hydroxy-substituted at C-7 and has been reduced across the 3,4 bond. It has a role as an EC 1.4.3.4 (monoamine oxidase) inhibitor and an algal metabolite. It derives from a hydride of a harman.
chebi: A harmala alkaloid in which the harman skeleton is hydroxy-substituted at C-7 and has been reduced across the 3,4 bond.
chembl: HARMALOL is a small molecule listed in the ChEMBL database but has not progressed to an approved clinical phase.
wikipedia: Harmalol is a bioactive β-carboline and a member of the harmala alkaloids.